Tyme Technologies
TYMEUnlisted companyTyme Technologies in brief
Tyme Technologies is an unlisted company in the Biotechnology industry, based in New Jersey, USA. It was founded in 2011. In the year to Dec 2020 it had sales of $0 M and a net loss of $29 M.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Tyme Technologies timeline
- 2011
- 🏁· approximateFounded
Events of Tyme Technologies from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Tyme Technologies
- Acquisitions and changes
- No longer listed: it is not in the SEC's, Nasdaq Trader's and FINRA's lists of US-traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #3,297 (Jan 2020) · #3,443 (Jan 2021) · #4,373 (Jan 2022)
Annual results
- Revenue
- $0 M
- Operating income
- —
- Net income
- $-29 M
Dec-2020 ending year
Lobbying by Tyme Technologies#
$200 K spent on lobbying the US Congress and federal agencies in 2020, most often on health issues.
- Health Issues4 reports
Lobbying firms hired in 2020
Baker & Hostetler LLP $200 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2020 | $200 K | — | 4 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Tyme Technologies, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
How Tyme Technologies compares in Biotechnology
- Revenue$0 M · higher than 0% of 647
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Tyme Technologies🇺🇸 | $105 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 7, 2022 (last known)
- Annual results:
- Dec-2020 ending year
- Balance sheet:
- Dec-2020 ending year
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Tyme Technologies? Verify and update this profile — free
Show Tyme Technologies's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.